Skip to main content
PVLA logo

PVLA · Palvella Therapeutics, Inc. · Debt

Track PVLA — free
$125.10 -1.29 (-1.02%) At close · Oct 23
Market Cap
$1.80B
Shares
14.41M
Volume · Oct 23 164.22K Avg daily vol (3M) 206.62K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-06-30 USD 217,000 10-Q filed 2026-08-04
Noncurrent operating lease liabilities 2026-06-30 USD 318,000 10-Q filed 2026-08-04
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1583648 CUSIP 697947109 13F (30d) 22 filings 22 filers Visit website Investor relations